70 related articles for article (PubMed ID: 8705251)
1. Delivery of oligonucleotides and polynucleotides.
Crooke ST
J Drug Target; 1995; 3(3):185-90. PubMed ID: 8705251
[No Abstract] [Full Text] [Related]
2. Oligonucleotides and polynucleotides as biologically active compounds.
Vlassov VV; Vlassova IE; Pautova LV
Prog Nucleic Acid Res Mol Biol; 1997; 57():95-143. PubMed ID: 9175432
[No Abstract] [Full Text] [Related]
3. Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery.
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW; Arien A; Brewster ME
J Control Release; 2006 Nov; 116(2):e26-8. PubMed ID: 17718951
[No Abstract] [Full Text] [Related]
4. Passive and facilitative transport of nucleobases, nucleosides, and oligonucleotides--application to antiviral and other therapies.
Brewster ME; Bodor N
NIDA Res Monogr; 1995; 154():61-85. PubMed ID: 8606750
[No Abstract] [Full Text] [Related]
5. Drug delivery of oligonucleotides by peptides.
Lochmann D; Jauk E; Zimmer A
Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952
[TBL] [Abstract][Full Text] [Related]
6. Studies on the intracellular release of genetic drugs from pharmaceutical carriers.
Lucas B; Remaut K; De Smedt SC; Demeester J
J Control Release; 2005 Jan; 101(1-3):402-5. PubMed ID: 15822237
[No Abstract] [Full Text] [Related]
7. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
9. Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: dendrimer synthesis, stability and oligonucleotide complexation.
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW; Arien A; Brewster ME
J Control Release; 2006 Nov; 116(2):e24-6. PubMed ID: 17718950
[No Abstract] [Full Text] [Related]
10. Delivery agents for oligonucleotides.
Seksek O; Bolard J
Methods Mol Biol; 2004; 252():545-68. PubMed ID: 15017080
[TBL] [Abstract][Full Text] [Related]
11. A study of the interaction of oligonucleotides with polynucleotides by the method of equilibrium gel filtration. The effect of magnesium ions and the composition of the oligonucleotides on the stability of the complex.
Chernaenko VM; Bresler SE
Mol Biol; 1975 Jan; 8(4):467-74. PubMed ID: 1128508
[TBL] [Abstract][Full Text] [Related]
12. Increased uptake of antisense oligonucleotides by delivery as double stranded complexes.
Astriab-Fisher A; Fisher MH; Juliano R; Herdewijn P
Biochem Pharmacol; 2004 Aug; 68(3):403-7. PubMed ID: 15242806
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanoscaled polyplex gene delivery systems.
Fernandez CA; Rice KG
Mol Pharm; 2009; 6(5):1277-89. PubMed ID: 19385668
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
[TBL] [Abstract][Full Text] [Related]
15. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
Fattal E; De Rosa G; Bochot A
Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
[TBL] [Abstract][Full Text] [Related]
16. Aspects of the transport and delivery of antisense oligonucleotides.
Juliano RL; Yoo H
Curr Opin Mol Ther; 2000 Jun; 2(3):297-303. PubMed ID: 11249624
[TBL] [Abstract][Full Text] [Related]
17. Novel delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model.
Ramakumar S; Phull H; Purves T; Funk J; Copeland D; Ulreich JB; Lai LW; Lien YH
J Urol; 2005 Sep; 174(3):1133-6. PubMed ID: 16094080
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
19. [Drug and gene delivery using electrotransfer].
Préat V
Ann Pharm Fr; 2001 Jul; 59(4):239-44. PubMed ID: 11468578
[TBL] [Abstract][Full Text] [Related]
20. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
